what are the main glp 1 drugs Market Overview: GLP-1 Agonists and Obesity Market | Blog Understanding GLP-1 Inhibitors: How They
Description
Common adverse effects include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting up to 40% of users) Reduced appetite and weight loss Injection site reactions redness, itching, or discomfort Hypoglycaemia particularly when used alongside insulin or sulfonylureas More serious but rare adverse effects include pancreatitis (inflammation of the pancreas) and gallbladder disease
( 10.2337/diacare.27.11.2628) [DOI] [PubMed] [Google Scholar] 9.Bhavsar S, Mudaliar S, Cherrington A
Mojsov received the prize for her discovery of glucagon-like peptide 1 (GLP-1), an incretin hormone produced by gut tissue that plays a key role in insulin secretion and glucose metabolism
By optimizing these experimental parameters, scientists can achieve highly reliable LC-MS analysis of GLP-1 peptide therapeutics
Other common side effects of GLP-1s include a sensation of early fullness, reduced appetite, vomiting, and diarrhea
Visceral abdominal fat and associated cardiometabolic risk
